HEADER RECEPTOR/PEPTIDE 05-OCT-09 2WUH TITLE CRYSTAL STRUCTURE OF THE DDR2 DISCOIDIN DOMAIN BOUND TO A TRIPLE- TITLE 2 HELICAL COLLAGEN PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DISCOIDIN DOMAIN RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: DISCOIDIN DOMAIN, RESIDUES 26-190; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: COLLAGEN PEPTIDE; COMPND 8 CHAIN: B, C, D; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: ACETYLATED N-TERMINUS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: 293-EBNA; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PCEP-PU; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS RECEPTOR-PEPTIDE COMPLEX, TRANSFERASE, NUCLEOTIDE-BINDING, TYROSINE- KEYWDS 2 PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR F.CARAFOLI,D.BIHAN,S.STATHOPOULOS,A.D.KONITSIOTIS,M.KVANSAKUL, AUTHOR 2 R.W.FARNDALE,B.LEITINGER,E.HOHENESTER REVDAT 3 20-DEC-23 2WUH 1 LINK REVDAT 2 02-FEB-10 2WUH 1 KEYWDS REMARK REVDAT 1 29-DEC-09 2WUH 0 JRNL AUTH F.CARAFOLI,D.BIHAN,S.STATHOPOULOS,A.D.KONITSIOTIS, JRNL AUTH 2 M.KVANSAKUL,R.W.FARNDALE,B.LEITINGER,E.HOHENESTER JRNL TITL CRYSTALLOGRAPHIC INSIGHT INTO COLLAGEN RECOGNITION BY JRNL TITL 2 DISCOIDIN DOMAIN RECEPTOR 2 JRNL REF STRUCTURE V. 17 1573 2009 JRNL REFN ISSN 0969-2126 JRNL PMID 20004161 JRNL DOI 10.1016/J.STR.2009.10.012 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH O.ICHIKAWA,M.OSAWA,N.NISHIDA,N.GOSHIMA,N.NOMURA,I.SHIMADA REMARK 1 TITL STRUCTURAL BASIS OF THE COLLAGEN-BINDING MODE OF DISCOIDIN REMARK 1 TITL 2 DOMAIN RECEPTOR 2. REMARK 1 REF EMBO J. V. 26 4168 2007 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 17703188 REMARK 1 DOI 10.1038/SJ.EMBOJ.7601833 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.D.KONITSIOTIS,N.RAYNAL,D.BIHAN,E.HOHENESTER,R.W.FARNDALE, REMARK 1 AUTH 2 B.LEITINGER REMARK 1 TITL CHARACTERIZATION OF HIGH AFFINITY BINDING MOTIFS FOR THE REMARK 1 TITL 2 DISCOIDIN DOMAIN RECEPTOR DDR2 IN COLLAGEN. REMARK 1 REF J.BIOL.CHEM. V. 283 6861 2008 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 18201965 REMARK 1 DOI 10.1074/JBC.M709290200 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.3 REMARK 3 NUMBER OF REFLECTIONS : 27359 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2726 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 293 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE : 0.3740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 37 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1845 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 176 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.38200 REMARK 3 B22 (A**2) : 0.99300 REMARK 3 B33 (A**2) : -2.37500 REMARK 3 B12 (A**2) : 6.95000 REMARK 3 B13 (A**2) : -2.35100 REMARK 3 B23 (A**2) : -4.02100 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.300 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.020 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.960 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.490 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.45 REMARK 3 BSOL : 57.25 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP-HYP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : A REMARK 3 TOPOLOGY FILE 2 : A REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2WUH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1290041324. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27359 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.28000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRIES 2QQJ AND 2V53 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 LEU A 15 REMARK 465 VAL A 16 REMARK 465 HIS A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 HIS A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 ALA A 23 REMARK 465 LEU A 24 REMARK 465 ALA A 25 REMARK 465 GLY A 190 REMARK 465 ACE B 3 REMARK 465 GLY D 31 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 26 CG OD1 ND2 REMARK 470 LYS A 138 CG CD CE NZ REMARK 470 ASP A 189 CA C O CB CG OD1 OD2 REMARK 470 GLN D 17 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 27 -9.21 -59.08 REMARK 500 ARG A 31 15.70 -145.04 REMARK 500 ALA A 71 176.37 174.20 REMARK 500 HIS A 92 -52.85 69.07 REMARK 500 LEU A 188 -177.92 68.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2032 DISTANCE = 6.49 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ACETYL GROUP (ACE): ACETYLATED N-TERMINUS OF COLLAGEN REMARK 600 PEPTIDE REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. DBREF 2WUH A 13 25 PDB 2WUH 2WUH 13 25 DBREF 2WUH A 26 190 UNP Q16832 DDR2_HUMAN 26 190 DBREF 2WUH B 3 31 PDB 2WUH 2WUH 3 31 DBREF 2WUH C 3 31 PDB 2WUH 2WUH 3 31 DBREF 2WUH D 3 31 PDB 2WUH 2WUH 3 31 SEQRES 1 A 178 ALA PRO LEU VAL HIS HIS HIS HIS HIS HIS ALA LEU ALA SEQRES 2 A 178 ASN PRO ALA ILE CYS ARG TYR PRO LEU GLY MET SER GLY SEQRES 3 A 178 GLY GLN ILE PRO ASP GLU ASP ILE THR ALA SER SER GLN SEQRES 4 A 178 TRP SER GLU SER THR ALA ALA LYS TYR GLY ARG LEU ASP SEQRES 5 A 178 SER GLU GLU GLY ASP GLY ALA TRP CYS PRO GLU ILE PRO SEQRES 6 A 178 VAL GLU PRO ASP ASP LEU LYS GLU PHE LEU GLN ILE ASP SEQRES 7 A 178 LEU HIS THR LEU HIS PHE ILE THR LEU VAL GLY THR GLN SEQRES 8 A 178 GLY ARG HIS ALA GLY GLY HIS GLY ILE GLU PHE ALA PRO SEQRES 9 A 178 MET TYR LYS ILE ASN TYR SER ARG ASP GLY THR ARG TRP SEQRES 10 A 178 ILE SER TRP ARG ASN ARG HIS GLY LYS GLN VAL LEU ASP SEQRES 11 A 178 GLY ASN SER ASN PRO TYR ASP ILE PHE LEU LYS ASP LEU SEQRES 12 A 178 GLU PRO PRO ILE VAL ALA ARG PHE VAL ARG PHE ILE PRO SEQRES 13 A 178 VAL THR ASP HIS SER MET ASN VAL CYS MET ARG VAL GLU SEQRES 14 A 178 LEU TYR GLY CYS VAL TRP LEU ASP GLY SEQRES 1 B 29 ACE GLY PRO HYP GLY PRO HYP GLY PRO HYP GLY PRO ARG SEQRES 2 B 29 GLY GLN HYP GLY VAL NLE GLY PHE HYP GLY PRO HYP GLY SEQRES 3 B 29 PRO HYP GLY SEQRES 1 C 29 ACE GLY PRO HYP GLY PRO HYP GLY PRO HYP GLY PRO ARG SEQRES 2 C 29 GLY GLN HYP GLY VAL NLE GLY PHE HYP GLY PRO HYP GLY SEQRES 3 C 29 PRO HYP GLY SEQRES 1 D 29 ACE GLY PRO HYP GLY PRO HYP GLY PRO HYP GLY PRO ARG SEQRES 2 D 29 GLY GLN HYP GLY VAL NLE GLY PHE HYP GLY PRO HYP GLY SEQRES 3 D 29 PRO HYP GLY MODRES 2WUH HYP B 6 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP B 9 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP B 12 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP B 18 PRO 4-HYDROXYPROLINE MODRES 2WUH NLE B 21 LEU NORLEUCINE MODRES 2WUH HYP B 24 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP B 27 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP B 30 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP C 6 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP C 9 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP C 12 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP C 18 PRO 4-HYDROXYPROLINE MODRES 2WUH NLE C 21 LEU NORLEUCINE MODRES 2WUH HYP C 24 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP C 27 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP C 30 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP D 6 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP D 9 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP D 12 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP D 18 PRO 4-HYDROXYPROLINE MODRES 2WUH NLE D 21 LEU NORLEUCINE MODRES 2WUH HYP D 24 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP D 27 PRO 4-HYDROXYPROLINE MODRES 2WUH HYP D 30 PRO 4-HYDROXYPROLINE HET HYP B 6 8 HET HYP B 9 8 HET HYP B 12 8 HET HYP B 18 8 HET NLE B 21 8 HET HYP B 24 8 HET HYP B 27 8 HET HYP B 30 8 HET ACE C 3 3 HET HYP C 6 8 HET HYP C 9 8 HET HYP C 12 8 HET HYP C 18 8 HET NLE C 21 8 HET HYP C 24 8 HET HYP C 27 8 HET HYP C 30 8 HET ACE D 3 3 HET HYP D 6 8 HET HYP D 9 8 HET HYP D 12 8 HET HYP D 18 8 HET NLE D 21 8 HET HYP D 24 8 HET HYP D 27 8 HET HYP D 30 8 HETNAM HYP 4-HYDROXYPROLINE HETNAM NLE NORLEUCINE HETNAM ACE ACETYL GROUP HETSYN HYP HYDROXYPROLINE FORMUL 2 HYP 21(C5 H9 N O3) FORMUL 2 NLE 3(C6 H13 N O2) FORMUL 3 ACE 2(C2 H4 O) FORMUL 5 HOH *176(H2 O) HELIX 1 1 PRO A 42 GLU A 44 5 3 HELIX 2 2 SER A 53 ALA A 57 5 5 SHEET 1 AA 5 ILE A 46 ALA A 48 0 SHEET 2 AA 5 LEU A 87 VAL A 100 -1 O GLN A 88 N THR A 47 SHEET 3 AA 5 LYS A 153 VAL A 169 -1 O LYS A 153 N VAL A 100 SHEET 4 AA 5 MET A 117 SER A 123 -1 O MET A 117 N VAL A 169 SHEET 5 AA 5 ILE A 130 SER A 131 -1 O ILE A 130 N TYR A 122 SHEET 1 AB 2 ILE A 46 ALA A 48 0 SHEET 2 AB 2 LEU A 87 VAL A 100 -1 O GLN A 88 N THR A 47 SSBOND 1 CYS A 30 CYS A 185 1555 1555 2.03 SSBOND 2 CYS A 73 CYS A 177 1555 1555 2.04 LINK C PRO B 5 N HYP B 6 1555 1555 1.34 LINK C HYP B 6 N GLY B 7 1555 1555 1.33 LINK C PRO B 8 N HYP B 9 1555 1555 1.34 LINK C HYP B 9 N GLY B 10 1555 1555 1.33 LINK C PRO B 11 N HYP B 12 1555 1555 1.34 LINK C HYP B 12 N GLY B 13 1555 1555 1.33 LINK C GLN B 17 N HYP B 18 1555 1555 1.34 LINK C HYP B 18 N GLY B 19 1555 1555 1.33 LINK C VAL B 20 N NLE B 21 1555 1555 1.33 LINK C NLE B 21 N GLY B 22 1555 1555 1.33 LINK C PHE B 23 N HYP B 24 1555 1555 1.35 LINK C HYP B 24 N GLY B 25 1555 1555 1.33 LINK C PRO B 26 N HYP B 27 1555 1555 1.34 LINK C HYP B 27 N GLY B 28 1555 1555 1.33 LINK C PRO B 29 N HYP B 30 1555 1555 1.34 LINK C HYP B 30 N GLY B 31 1555 1555 1.33 LINK C ACE C 3 N GLY C 4 1555 1555 1.33 LINK C PRO C 5 N HYP C 6 1555 1555 1.34 LINK C HYP C 6 N GLY C 7 1555 1555 1.33 LINK C PRO C 8 N HYP C 9 1555 1555 1.34 LINK C HYP C 9 N GLY C 10 1555 1555 1.33 LINK C PRO C 11 N HYP C 12 1555 1555 1.34 LINK C HYP C 12 N GLY C 13 1555 1555 1.33 LINK C GLN C 17 N HYP C 18 1555 1555 1.34 LINK C HYP C 18 N GLY C 19 1555 1555 1.33 LINK C VAL C 20 N NLE C 21 1555 1555 1.33 LINK C NLE C 21 N GLY C 22 1555 1555 1.33 LINK C PHE C 23 N HYP C 24 1555 1555 1.34 LINK C HYP C 24 N GLY C 25 1555 1555 1.33 LINK C PRO C 26 N HYP C 27 1555 1555 1.34 LINK C HYP C 27 N GLY C 28 1555 1555 1.33 LINK C PRO C 29 N HYP C 30 1555 1555 1.34 LINK C HYP C 30 N GLY C 31 1555 1555 1.33 LINK C ACE D 3 N GLY D 4 1555 1555 1.33 LINK C PRO D 5 N HYP D 6 1555 1555 1.34 LINK C HYP D 6 N GLY D 7 1555 1555 1.33 LINK C PRO D 8 N HYP D 9 1555 1555 1.34 LINK C HYP D 9 N GLY D 10 1555 1555 1.33 LINK C PRO D 11 N HYP D 12 1555 1555 1.34 LINK C HYP D 12 N GLY D 13 1555 1555 1.33 LINK C GLN D 17 N HYP D 18 1555 1555 1.34 LINK C HYP D 18 N GLY D 19 1555 1555 1.33 LINK C VAL D 20 N NLE D 21 1555 1555 1.33 LINK C NLE D 21 N GLY D 22 1555 1555 1.33 LINK C PHE D 23 N HYP D 24 1555 1555 1.34 LINK C HYP D 24 N GLY D 25 1555 1555 1.33 LINK C PRO D 26 N HYP D 27 1555 1555 1.34 LINK C HYP D 27 N GLY D 28 1555 1555 1.33 LINK C PRO D 29 N HYP D 30 1555 1555 1.34 CISPEP 1 GLU A 156 PRO A 157 0 0.29 CRYST1 33.397 40.863 48.917 66.19 88.90 76.92 P 1 3 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029943 -0.006957 0.002498 0.00000 SCALE2 0.000000 0.025124 -0.011296 0.00000 SCALE3 0.000000 0.000000 0.022418 0.00000